Cis-dichlorodiammineplatinum (II) (cis-platinum) and etoposide for patients with refractory lymphomas

Cancer Treat Rev. 1982 Jun:9 Suppl:45-52. doi: 10.1016/s0305-7372(82)80077-7.
No abstract available

MeSH terms

  • Adult
  • Cisplatin / administration & dosage*
  • Cisplatin / adverse effects
  • Drug Therapy, Combination
  • Etoposide / administration & dosage*
  • Etoposide / adverse effects
  • Female
  • Humans
  • Lymphoma / drug therapy*
  • Male
  • Middle Aged
  • Podophyllotoxin / analogs & derivatives*

Substances

  • Etoposide
  • Podophyllotoxin
  • Cisplatin